Prestige 5+WNV Horse Vaccine

MERCK ANIMAL HEALTH
Intervet Inc.
126 E. LINCOLN AVENUE, PO BOX 2000, Rahway, NJ, 07065
Customer Service: 800-521-5767
Technical Service (Companion Animal): 800-224-5318
Technical Service (Livestock): 800-211-3573
Website: www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
Prestige® 5 + WNV

Intervet/Merck Animal Health

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA - WEST NILE VIRUS VACCINE, EASTERN & WESTERN, KILLED VIRUS, KILLED FLAVIVIRUS CHIMERA, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus - flavivirus chimera and tetanus toxoid.

INDICATIONS: This product has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown to be at least 6 months for EIV. Duration of immunity for Eastern and Western Encephalomyelitis Viruses, EHV-1, EHV-4, tetanus and West Nile Virus has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown effective against virus shedding of EIV, EHV-1 and EHV-4, and encephalitis and viremia caused by West Nile Virus.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.

CAUTIONS: Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 4855.R2

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html





Code



10 DOSES

10 x 1 mL Syringes with Separate Sterile Needles

192936

310664-02

10 Doses

10 mL

182299

353798-02

CPN: 1047535.1